Boston, MA -- (SBWIRE) -- 08/21/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (E Commerce China Dangdang Inc (ADR)(NYSE:DANG), Hovnanian Enterprises, Inc.(NYSE:HOV), Magnum Hunter Resources Corp(NYSE:MHR), XOMA Corp(NASDAQ:XOMA)
E Commerce China Dangdang Inc (ADR)(NYSE:DANG) shares lost 7.74% to $8.46. E-Commerce China Dangdang Inc. (Dangdang) is a holding company. It is a business-to-consumer (B2C), e-commerce Company in the People’s Republic of China. As of September 30, 2010, it offered approximately 590,000 book titles on its Website, including more than 570,000 Chinese language titles.
How Should Investors Trade DANG After The Recent Volatility? Get Free Report Here
Hovnanian Enterprises, Inc.(NYSE:HOV) shares went up 4.35% to $5.28. Hovnanian Enterprises, Inc. (Hovnanian) designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, mid-rise condominiums, urban infill and active adult homes in planned residential developments.
How Should Investors Trade HOV After The Recent Volatility? Get Free Report Here
Magnum Hunter Resources Corp(NYSE:MHR) shares lost 1.23% to $4.00. Magnum Hunter Resources Corporation (Magnum Hunter) is an independent oil and gas company engaged in the exploration for and the exploitation, acquisition, development and production of crude oil, natural gas and natural gas liquids, primarily in the states of West Virginia, Ohio, Texas, Kentucky and North Dakota and in Saskatchewan, Canada.
Is MHR A Good Buy After The Recent Price Movement? Find Out Here
XOMA Corp(NASDAQ:XOMA) shares jumped 12.43% to $4.07. XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta).
Is XOMA A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)